Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,416.00
Bid: 12,408.00
Ask: 12,410.00
Change: -12.00 (-0.10%)
Spread: 2.00 (0.016%)
Open: 12,474.00
High: 12,480.00
Low: 12,350.00
Prev. Close: 12,428.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Oil and shares slide as sanctions, virus fears strike

Tue, 23rd Mar 2021 12:56

(Recasts)

* U.S., Europe sanctions against China hit shares

* Powell to testify from 1600 GMT on U.S. recovery

* Oil slides 4% amid demand fears

* Global currencies vs. dollar https://tmsnrt.rs/2PmYOcE

By Lawrence White and Alun John

LONDON/HONG KONG, March 23 (Reuters) - Oil prices slumped
and shares slipped from a one-year peak on Tuesday as a wave of
coronavirus infections, a fresh lockdown in Germany, and U.S.
and European sanctions over China combined to curb risk appetite
worldwide.

Brent crude futures dropped by $2.59, or 4%, to
$62.03 a barrel by 1225 GMT and U.S. West Texas Intermediate
(WTI) crude futures likewise slid 4% on concerns that new
pandemic curbs and slow vaccine rollouts in Europe will hold
back a recovery in demand.

Energy stocks were also hit, with Chevron Corp,
Occidental Petroleum Corp and Exxon Mobil Corp
shedding between 1.5% and 3.5% pre-market, while travel-related
stocks also fell as much as 4%.

The STOXX index of 600 European shares slipped
0.4%, while the benchmark 10-year German government bond yield
dropped 4 basis points to -0.351%, its lowest in a
week, and gold inched up as investors sought safer assets.

U.S. stock index futures slid ahead of Congressional
testimony by Federal Reserve Chair Jerome Powell and Treasury
Secretary Janet Yellen later in the day that may shed light on
the pace of economic rebound from the COVID-19 pandemic.

In remarks prepared for delivery to the hearing on Tuesday
morning, Powell said the U.S. economic recovery had progressed
"more quickly than generally expected".

The congressional hearings begin at 12 p.m. ET (1600 GMT).

"The FOMC last week laid out pretty clearly what the Fed's
view is with regard to rates ... the next thing that markets
will focus on is maybe getting some details from Yellen with
regard to further infrastructure investment," said Alex Wolf,
head of investment strategy for Asia at J.P. Morgan Private
Bank, referring to a statement from the Federal Open Market
Committee.

MIXED MOOD

A mixed bag of new Western sanctions on China, coronavirus
concerns and Turkish tumult after President Tayyip Erdogan's
shock sacking of the central bank chief at the weekend left
investors awaiting a firmer signal.

The Turkish lira appeared to find a floor after
Monday's historic 7.5% slump, rising as much as 1% in volatile
trading to 7.8742 against the dollar by 1234 GMT.

In Asia, MSCI's broadest index of Asia-Pacific shares
outside Japan dropped 0.66%, hurt by a 0.95%
fall in Chinese blue chips as a fresh wave of U.S. and
European sanctions over human rights abuses in Xinjiang hit.

The sanctions on China prompted an immediate riposte from
Beijing against the EU that appeared broader, including European
lawmakers, diplomats, institutes and families.

Adding to market jitters were further worries over the
efficacy of the AstraZeneca Plc vaccine developed with
Oxford University after a U.S. health agency said the drugmaker
may have included outdated information in its data.

SUMMER CANCELLED?

The fall in oil prices, travel and energy-related stocks was
spearheaded by news Germany had extended its lockdown until
April 18, reversing plans for a gradual reopening of the economy
agreed earlier this month.

"Global travel is still looking like it could be a while
away," said Matt Stanley, a fuel broker at Star Fuels in Dubai,
adding that a second-half recovery in oil demand looked doubtful
as lockdowns remain the order of the day.

Benchmark 10-year U.S. Treasury notes last
yielded 1.6523%, down from 1.732% late on Friday.

The dollar gained slightly against a basket of six major
currencies, last trading at 92.1, having slipped 0.32% on
Monday, while making advances against the kiwi, Aussie and
sterling.

Spot gold rose slightly to $1,740 per ounce by 1239
GMT, buoyed by easing U.S. Treasury yields.

The New Zealand dollar hit a three-month low after
the government introduced taxes to curb housing speculation, a
move investors reckoned could allow the central bank to hold low
interest rates for longer with less risk of a property bubble.

(Reporting by Alun John in Hong Kong, Chris Prentice in
Washington, Lawrence White in London; Additional reporting by
Luoyan Liu in Shanghai; Editing by Catherine Evans)

More News
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.